Evaluation of therapeutic effect of Tiotropium Bromide in early stages of chronic obstructive pulmonary disease in patients of subspecialty clinics of Isfahan university of medical science in 2018 - 201

Phase 3

Recruiting

• Conditions: Chronic obstructive pulmonary disease.; Chronic obstructive pulmonary disease, unspecified; J44.9

• Registration Number: IRCT20190524043684N1
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 November 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 92

Inclusion Criteria

age between 40 - 80 years
History of COPD stage GOLD 1 , 2
FEV1 to FVC ratio less than 0.7 after bronchodilator use

Exclusion Criteria

Not signing informed consent

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
FEV1. Timepoint: 0 , 1 , 3 , 6 moths after first visit. Method of measurement: spirometry.;FVC. Timepoint: 0 , 1 , 3 , 6 moths after first visit. Method of measurement: spirometry.;FEV1/FVC. Timepoint: 0 , 1 , 3 , 6 moths after first visit. Method of measurement: spirometry.